Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Birgit Schramm"'
Autor:
Birgit Schramm, Rodrigue C Nganaboy, Piex Uwiragiye, Didier Mukeba, Aboubacar Abdoubara, Illa Abdou, Jean-Claude Nshimiymana, Seyni Sounna, Laurent Hiffler, Laurence Flevaud, Helena Huerga
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256717 (2021)
[This corrects the article DOI: 10.1371/journal.pone.0250933.].
Externí odkaz:
https://doaj.org/article/8c0f557e63d041d791c6b86806f9bcce
Autor:
Birgit Schramm, Rodrigue C Nganaboy, Piex Uwiragiye, Didier Mukeba, Aboubacar Abdoubara, Illa Abdou, Jean-Claude Nshimiymana, Seyni Sounna, Laurent Hiffler, Laurence Flevaud, Helena Huerga
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250933 (2021)
BackgroundTuberculosis (TB) is a serious co-morbidity among children with severe acute malnutrition (SAM) and TB diagnosis remains particularly challenging in the very young. We explored whether, in a low HIV-prevalence setting, the detection of myco
Externí odkaz:
https://doaj.org/article/294f88e3189e4023b24abd9465796e0b
Autor:
W. Robert Taylor, Htee Khu Naw, Kathryn Maitland, Thomas N. Williams, Melissa Kapulu, Umberto D’Alessandro, James A. Berkley, Philip Bejon, Joseph Okebe, Jane Achan, Alfred Ngwa Amambua, Muna Affara, Davis Nwakanma, Jean-Pierre van Geertruyden, Muhindo Mavoko, Pascal Lutumba, Junior Matangila, Philipe Brasseur, Patrice Piola, Rindra Randremanana, Estrella Lasry, Caterina Fanello, Marie Onyamboko, Birgit Schramm, Zolia Yah, Joel Jones, Rick M. Fairhurst, Mahamadou Diakite, Grace Malenga, Malcolm Molyneux, Claude Rwagacondo, Charles Obonyo, Endalamaw Gadisa, Abraham Aseffa, Mores Loolpapit, Marie-Claire Henry, Grant Dorsey, Chandy John, Sodiomon B. Sirima, Karen I. Barnes, Peter Kremsner, Nicholas P. Day, Nicholas J. White, Mavuto Mukaka
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-14 (2018)
Abstract Background In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), without testing for glucose-6-phosphate dehydr
Externí odkaz:
https://doaj.org/article/2a4bf5506f7541d1a72a265703af4086
Autor:
Tom Ellman, Lakshmi Jain, Lubbe Wiesner, Valarie Opollo, Elisabeth Szumilin, Gilles van Cutsem, Gisele Mucinya, Elisabeth Poulet, Claire Bossard, David Maman, Stephen Wanjala, Birgit Schramm
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Supplemental Digital Content is Available in the Text.
Background: Patients hospitalized with advanced HIV have a high mortality risk. We assessed viremia and drug resistance among differentiated care services and explored whether expediting the
Background: Patients hospitalized with advanced HIV have a high mortality risk. We assessed viremia and drug resistance among differentiated care services and explored whether expediting the
Autor:
Ephrahim Ajule, Johanna Wapling, Reuben Mwenda, Ankur Rakesh, Birgit Schramm, Sarala Nicholas, Charles Kiyaga, Suna Balkan, Liselotte Wolters, Elisabeth Poulet, Monique Gueguen, Elisabeth Szumilin
Publikováno v:
Tropical Medicine & International Health. 26:184-194
We monitored a large-scale implementation of the Simple Amplification-Based Assay semi-quantitative viral load test for HIV-1 version I (SAMBA I Viral Load = SAMBA I VL) within Médecins Sans Frontières' HIV programmes in Malawi and Uganda, to asses
Autor:
Birgit Schramm, Elvis Temfack, Diane Descamps, Sarala Nicholas, Gilles Peytavin, Joseph E Bitilinyu-Bangoh, Alexandre Storto, Minh P Lê, Basma Abdi, Janet Ousley, Thokozani Kalua, Vincent Calvez, Andreas Jahn, Anne-Geneviève Marcelin, Elisabeth Szumilin
Publikováno v:
Schramm, Birgit; Temfack, Elvis; Descamps, Diane; Nicholas, Sarala; Peytavin, Gilles; Bitilinyu-Bangoh, Joseph E; Storto, Alexandre; Lê, Minh P; Abdi, Basma; Ousley, Janet; Kalua, Thokozani; Calvez, Vincent; Jahn, Andreas; Marcelin, Anne-Geneviève; Szumilin, Elisabeth (2022). Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort study. Lancet HIV, 9(8), e544-e553. Elsevier 10.1016/S2352-3018(22)00136-9
BACKGROUND Many countries are now replacing non-nucleoside reverse transcriptase inhibitor (NNRTI)-based first-line antiretroviral therapy (ART) with a regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir (TLD). Recognising
Autor:
Laurent Hiffler, Piex Uwiragiye, Birgit Schramm, Jean-Claude Nshimiymana, Illa Abdou, Laurence Flevaud, Rodrigue C. Nganaboy, Helena Huerga, Aboubacar Abdoubara, Didier Mukeba, Seyni Sounna
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 5, p e0250933 (2021)
PLoS ONE, Vol 16, Iss 5, p e0250933 (2021)
Background Tuberculosis (TB) is a serious co-morbidity among children with severe acute malnutrition (SAM) and TB diagnosis remains particularly challenging in the very young. We explored whether, in a low HIV-prevalence setting, the detection of myc
Autor:
F. Fily, Sarala Nicholas, C. Delaugerre, Emmanuel Tiyo Ayikobua, Suna Balkan, Pontiano Kaleebu, I. Amoros Quiles, Estelle Pasquier, Deogratius Ssemwanga, Birgit Schramm
Publikováno v:
Tropical Medicine & International Health. 23:1075-1083
OBJECTIVES The number of patients on second-line antiretroviral therapy is growing, but data on HIV drug resistance patterns at failure in resource-constrained settings are scarce. We aimed to describe drug resistance and investigate the factors asso
Autor:
D Vaz, Iza Ciglenecki, R M Cuco, Valentina Carnimeo, J S Mulassua, Birgit Schramm, J de Amaral Fidelis, I A Pulido Tarquino, S Lobo, A Couto, Lucas Molfino, S Fuentes, Tom Ellman, N Tamayo Antabak
Publikováno v:
JAC-Antimicrobial Resistance
Background HIV drug resistance (HIV-DR) is rising in sub-Saharan Africa in both ART-naive and ART-experienced patients. Objectives To estimate the level of acquired DR (ADR) and pre-treatment DR (PDR) across selected urban and rural sites in Southern
Autor:
Elisabeth Sanchez-Padilla, Nazir Ahmed Ismail, Thomas Kohl, Christian Utpatel, Patrick Beckert, Stefan Niemann, Claudio U. Köser, Harald Hoffmann, Sönke Andres, Robin M. Warren, Bouke C. de Jong, Marisa Klopper, Matthias Merker, Florian P. Maurer, Shaheed V. Omar, Katharina Kranzer, Maryline Bonnet, Bernhard Kerschberger, Viola Dreyer, Ivan Barilar, Elisa Ardizzoni, Birgit Schramm, Gugu Maphalala
Publikováno v:
Genome Medicine
Genome Medicine, 2020, 12 (1), pp.104. ⟨10.1186/s13073-020-00793-8⟩
Genome Medicine, 2020, 12 (1), pp.104. ⟨10.1186/s13073-020-00793-8⟩
Background Multidrug-resistant (MDR) Mycobacterium tuberculosis complex strains not detected by commercial molecular drug susceptibility testing (mDST) assays due to the RpoB I491F resistance mutation are threatening the control of MDR tuberculosis (